MOMTAZEE JAMES C Insider Trades

Insider Trading History

Track insider trading activity for MOMTAZEE JAMES C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BridgeBio Pharma
BridgeBio Pharma BBIO
Director
Holding Value $1.58M 19,070 shares
Last Trade
Jun 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$639k 9,267 shares
$68.92
$82.66
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.82M 109,499 shares
Last Trade
Apr 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 469 shares
$29.83
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.82M 109,405 shares
Last Trade
Apr 17, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.8k 94 shares
$29.83
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.81M 109,152 shares
Last Trade
Jan 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 609 shares
$22.98
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.8M 109,030 shares
Last Trade
Jan 20, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.8k 122 shares
$22.98
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.79M 108,543 shares
Last Trade
Oct 20, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.8k 158 shares
$17.74
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.79M 108,701 shares
Last Trade
Oct 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 789 shares
$17.72
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.77M 107,912 shares
Last Trade
Sep 10, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$45.2k 3,282 shares
$13.77
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.88M 111,194 shares
Last Trade
Sep 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$464k 33,726 shares
$13.77
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.37M 96,670 shares
Last Trade
Jul 17, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.81k 241 shares
$11.65
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.38M 96,911 shares
Last Trade
Jul 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 1,201 shares
$11.65
$34.89
BridgeBio Pharma
BridgeBio Pharma BBIO
Director
Holding Value $7.86M 95,080 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$352k 8,425 shares
$41.73
$82.66
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.34M 95,710 shares
Last Trade
Apr 17, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.8k 276 shares
$10.15
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.35M 95,986 shares
Last Trade
Apr 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 1,379 shares
$10.15
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.3M 94,607 shares
Last Trade
Jan 23, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.43k 306 shares
$11.21
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.31M 94,913 shares
Last Trade
Jan 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 1,248 shares
$11.21
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.27M 93,665 shares
Last Trade
Oct 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.3k 1,231 shares
$11.62
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.23M 92,434 shares
Last Trade
Sep 12, 2024 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$37k 3,056 shares
$12.12
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $3.33M 95,490 shares
Last Trade
Sep 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340k 27,894 shares
$12.19
$34.89
Roivant Sciences
Roivant Sciences ROIV
Director
Holding Value $2.76M 79,091 shares
Last Trade
Jul 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.1k 1,555 shares
$11.01
$34.89

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up